Navigation Links
Cordis Unveils Next Generation CoCr Coronary Stent
Date:3/11/2010

WATERLOO, Belgium, March 11, 2010 /PRNewswire/ --

- PRESILLION(TM) PLUS CoCr Coronary Stent Offers New Levels of Delivery, Support and Restoration for Arteriosclerotic Arteries

Cordis Corporation today announced the European launch of its next generation of bare metal stent system - PRESILLION(TM) PLUS. The new stent system, which improves upon the ground-breaking PRESILLION(TM), features important technological advances designed to gain easier access to distal lesions and help restore the artery's natural form.

"The new upgraded delivery system increases the speed of procedures with atraumatic delivery, increased pushability, and smoother withdrawal. We are very satisfied with the speed in which we were able to incorporate feedback from cardiologists into the new design," said Campbell Rogers MD, Global Head of R&D of Cordis Corporation.

The PRESILLION(TM) PLUS changes include a new hypotube for improved pushability in crossing calcified lesions and a redesigned semi-compliant balloon for precise stent deployment and decreased deflation time.

The PRESILLION(TM) PLUS stent is available in lengths from 8 to 33mm including a new 28mm addition and in diameters from 2.5 to 4.0mm.

The PIONIR study, designed to measure the safety and effectiveness of PRESILLION(TM) and PRESILLION(TM) PLUS, completed enrollment at 16 sites in Europe and Israel. The study, conducted by Medinol, includes 278 patients and will evaluate clinical performance through one year.

"Our vision at Cordis is to transform cardiovascular care, a field in which incredible progress has been made over the last decade, but one in which much more remains to be done. The new PRESILLION(TM) PLUS further complements our portfolio with its technological advances. We will continue to deliver innovative new solutions that save lives and improve the quality of life for people around the world," said Staffan Ternstrom, President, Cordis Europe, Middle-East, Africa.

Cordis Corporation is the exclusive global distributor of PRESILLION(TM) PLUS, which is designed and manufactured by Medinol Ltd, Israel. PRESILLION (TM) PLUS is a trademark of Cordis Corporation.

About Cordis Corporation

Cordis Corporation, a Johnson & Johnson company, is a worldwide leader in the development and manufacture of interventional vascular technology. Through the company's innovation, research and development, Cordis partners with interventional cardiologists worldwide to treat millions of patients who suffer from vascular disease. More information about Cordis Corporation can be found at http://www.cordis.com.

Cordis Corporation signed an exclusive distribution agreement with Medinol in 2008 and will be distributing PRESILLION (TM) PLUS globally. Medinol is a stent innovation company that develops both stents and delivery systems through design innovation and advanced manufacturing technologies.

    Media Contacts: Isabella Sharp
    APCO Worldwide
    isharp@apcoworldwide.com
    +44(0)20-7526-3632
    +44(0)7813-307490


SOURCE Cordis Corporation

Back to top
'/>"/>
SOURCE Cordis Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. DUSA Unveils Ergonomic Enhancements to BLU-U(R) at the American Academy of Dermatology Annual Meeting
2. FamilyCord Unveils Safer and More Effective Cord Blood Collection Kit
3. Quest Diagnostics Unveils Care360(TM) EHR
4. FDA Unveils Initiative to Reduce Unnecessary Radiation Exposure from Medical Imaging
5. Slovenias Sole Radiotherapy Hospital Unveils Novalis Tx(TM) Platform From Varian and BrainLAB
6. Siemens Unveils Flexible Financing Solutions to Help Providers Achieve Meaningful Use
7. National Expressions of Courage Art Contest Unveils Stories of Inspiration
8. Aflex Unveils Revolutionary New Hose Design for the Chemical and Process Industry
9. Siemens Unveils New Hearing Loss Options at SPLASH: ADAs 2009 Convention
10. Ethicon Endo-Surgery Unveils Full Energy Portfolio for First Time at American College of Surgeons Clinical Congress
11. Eurotech Unveils New Diabetes Care Management Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... IRIDEX Corporation (NASDAQ: IRIX ) today ... common stock, $0.01 par value (the "Offering" with such shares ... final terms of the Offering will depend on market and ... be no assurance as to whether or when the Offering ... net proceeds it will receive from this offering for working ...
(Date:12/8/2016)... Dec. 8, 2016 KEY FINDINGS ... Patient warming ... of blood during surgeries, lowering the risks of neurological disorders ... of SSIs. The patient warming systems can be segmented into ... benefits in turn reduce the stay at hospitals thus, lowering ...
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... poised to grow in 2017-2023. Various reasons for growth ... obese population, higher incidences of chronic diseases, high recovery ... mobility aid services. Medical lifting sling refers to ... with limited mobility. These slings connect to the lift ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... The Holy Name Medical Center ... NY, on December 3rd, to benefit Holy Name Medical Center's programs and services. ... raised over $1 million - the largest event in the Center's history, both ...
(Date:12/9/2016)... ... December 09, 2016 , ... "I had a terrible time trying ... Va. "I thought that if the nebulizer had a more child-friendly design, then children ... , He developed the patent-pending NEBY to avoid the need to deliver medication via ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... will become Quality Insights beginning January 1, 2017. The name change aligns ... commitment to measuring and improving health care quality. , “We are very proud ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Research Institute (WCRI) officially opened registration today for its 33rd Annual Issues ... Boston, MA . , The theme of the conference is “Persistent Challenges and ...
(Date:12/8/2016)... ... December 08, 2016 , ... ZyDoc ... Language Processing–Enabled and Conventional Data Capture Methods for Input to Electronic Health Records: ... , Results of the comparative usability study demonstrate that a dictation-based method (“NLP ...
Breaking Medicine News(10 mins):